During Monday’s trading session, the shares of a company operating in the B2B Human Cloud segment in India hit a 5 percent upper circuit at Rs. 317.65 on NSE, after the company announced H1 FY25 financial results with a rise in net profit by 42 percent YoY.
With a market cap of Rs. 307.8 crores, the shares of Infollion Research Services Limited opened in the green at Rs. 317.65, compared to its previous closing price of Rs. 302.55.
What’s the news:
The fluctuations in the share prices were also observed after Infollion Research Services Limited announced the financial results for H1FY25, through the recent filings with the NSE on Monday during market hours.
In H1 FY25, the consolidated revenue from operations reached Rs. 35.2 crores, marking a half-yearly growth of around 32.2 percent from Rs. 26.63 crores in H2 FY24, and a nearly 41 percent rise year-on-year from Rs. 25 crores in H1 FY24.
Additionally, Infollion Research Services saw a year-on-year consolidated net profit rise of 42.2 percent, reaching Rs. 6 crores in H1 FY25, up from Rs. 4.22 crores in H1 FY24. The company’s net profit also grew by 38.6 percent compared to Rs. 4.33 crores in H2 FY24.
Shareholding Pattern:
According to the March 2024 shareholding pattern, the Promoters hold a 51.73 percent stake in the company, while the Retail Investors and Domestic Institutional Investors (DIIs) hold 44.91 percent and 3.36 percent, respectively, in Infollion Research Services.
About the company:
Incorporated in 2009, Infollion Research Services Limited is mainly engaged in the business of providing service of on-demand contingent hiring under the brand name of “INFOLLION”.
The company operates as a hub for expert professionals within the B2B Human cloud segment of the gig economy. On June 8, 2023, the company made its debut on the National Stock Exchange (NSE).
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.